Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances in the Diagnosis and Treatment of Vasculitis / / edited by Luis M. Amezcua-Guerra
| Advances in the Diagnosis and Treatment of Vasculitis / / edited by Luis M. Amezcua-Guerra |
| Pubbl/distr/stampa | [Place of publication not identified] : , : IntechOpen, , 2011 |
| Descrizione fisica | 1 online resource (380 pages) |
| Disciplina | 616.079 |
| Soggetto topico |
Immunology
Vasculitis |
| ISBN | 953-51-6556-9 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910138163503321 |
| [Place of publication not identified] : , : IntechOpen, , 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in the Etiology, Pathogenesis and Pathology of Vasculitis / / edited by Luis M. Amezcua-Guerra
| Advances in the Etiology, Pathogenesis and Pathology of Vasculitis / / edited by Luis M. Amezcua-Guerra |
| Pubbl/distr/stampa | [Place of publication not identified] : , : IntechOpen, , 2011 |
| Descrizione fisica | 1 online resource (450 pages) |
| Disciplina | 616.079 |
| Soggetto topico |
Immunology
Vasculitis |
| ISBN | 953-51-6527-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910138162903321 |
| [Place of publication not identified] : , : IntechOpen, , 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The heart in systemic autoimmune diseases / / edited by Fabiola Atzeni, Rheumatology Unit, L. Sacco University Hospital, Milan Italy, Andrea Doria, Department of Medicine and Pheumatology Unit, University of Padova Medical School, Padova, Italy [and three others]
| The heart in systemic autoimmune diseases / / edited by Fabiola Atzeni, Rheumatology Unit, L. Sacco University Hospital, Milan Italy, Andrea Doria, Department of Medicine and Pheumatology Unit, University of Padova Medical School, Padova, Italy [and three others] |
| Autore | Atzeni Fabiola |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Amsterdam ; ; Cambridge, Massachusetts : , : Elsevier, , [2017] |
| Descrizione fisica | 1 online resource (xxiii, 542 pages) : illustrations (some color) |
| Disciplina | 616.1079 |
| Collana | Handbook of systemic autoimmune diseases |
| Soggetto topico |
Heart - Diseases - Immunological aspects
Autoimmune diseases Cardiological manifestations of general diseases Atherosclerosis - Immunological aspects Vasculitis |
| ISBN |
0-444-63669-2
0-12-803997-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover -- The Heart in Systemic Autoimmune Diseases -- Handbook of Systemic Autoimmune Diseases -- Handbook of Systemic Autoimmune Diseases -- Copyright -- Dedication -- Contents -- List of Contributors -- Preface -- 1 - Cellular Immunity: A Role for Cytokines -- 1. INTRODUCTION -- 2. AUTOIMMUNITY IN MYOCARDITIS -- 3. PATHOGENESIS: THE ROLE OF CELLS AND CYTOKINES -- 3.1 Viral Mouse Model -- 3.2 Cardiac Myosin Mouse Model -- 3.3 Role of Cells -- 3.4 Role of Cytokines -- 3.5 Summary of Pathogenic Mechanisms -- REFERENCES -- FURTHER READING -- 2 - Organ-Specific Autoimmunity Involvement in Cardiovascular Disease -- 1. INTRODUCTION -- 2. POST-MYOCARDIAL INFARCTION (DRESSLER) SYNDROME -- 2.1 Anti-Heart Autoantibodies -- 3. POST-PERICARDIOTOMY SYNDROME AND IDIOPATHIC RECURRENT ACUTE PERICARDITIS -- 3.1 Anti-Heart Autoantibodies -- 4. RHEUMATIC CARDITIS -- 4.1 Immune Pathogenesis of Rheumatic Carditis -- 4.1.1 Antistreptococcus Antibodies -- 4.1.2 Anti-heart Autoantibodies -- 5. DILATED CARDIOMYOPATHY AND MYOCARDITIS -- 5.1 Immune Pathogenesis of Myocarditis and Dilated Cardiomyopathy -- 5.2 Anti-Heart Autoantibodies by s-I IFL -- 5.3 Anti-Heart Autoantibodies by s-I IFL: Technical Considerations and Proposed Nomenclature -- 5.4 Autoantibodies to Myosin Heavy Chain and Other Autoantigens by Immunoblotting Techniques -- 5.5 Autoantibodies to Sarcolemmal Na-K-ATPase -- 5.6 Autoantibodies to Mitochondrial and to Extracellular Matrix Antigens -- 5.7 Blocking and Stimulating Autoantibodies to β-Adrenergic Receptors -- 5.8 Autoantibodies to M2-Muscarinic Receptors -- 5.9 Cardiac-Specific Antibodies in Myocarditis/DCM: Clinical Correlates and Potential Functional Role -- 6. IDIOPATHIC TACHY AND BRADYARRHYTHMIAS -- 6.1 Cardiac Conducting Tissue Antibodies -- 6.2 Stimulating Autoantibodies to β-Adrenergic Receptors -- 7. SYSTEMIC ARTERIAL HYPERTENSION.
7.1 Anti-Heart Autoantibodies by s-I IFL -- 7.2 Stimulating Autoantibodies to α1-Adrenergic Receptors -- 7.3 Stimulating Autoantibodies to the Angiotensin Receptor -- REFERENCES -- 3 - Neonatal Lupus Syndromes: Pathogenesis and Clinical Featuresa -- 1. INTRODUCTION -- 2. EPIDEMIOLOGY AND DEFINITION OF CONGENITAL COMPLETE AVB -- 3. ETIOLOGY/PATHOGENESIS -- 3.1 Myocarditis -- 3.2 Arrhythmogenesis and Electrophysiological Effects -- 3.3 Apoptosis, TGFbeta, TLR, and the Road to Scar -- 3.4 Genetics -- 3.5 Evaluation of the Fine Specificities of the Maternal Autoantibody Profile -- 3.6 Other Pathogenetic Mechanisms -- 4. RISK OF DELIVERING A CHILD WITH COMPLETE CHB -- 5. CLINICAL MANIFESTATIONS -- 5.1 Cardiac Manifestations -- 5.2 Non-Cardiac Manifestations -- 6. TREATMENT -- 6.1 Fluorinated Corticosteroids -- 6.2 Other Possible Therapies -- 6.3 Postnatal Treatment -- 7. OBSTETRIC MANAGEMENT OF PREGNANCIES AT RISK OF DEVELOPING CCHB -- 8. PROGNOSIS -- 8.1 Infants -- 8.2 Maternal -- 9. OTHER PREGNANCY OUTCOMES IN WOMEN WITH ANTI-RO/SSA ANTIBODIES -- 10. ANTI-RO/SSA NEGATIVE CHB -- ACKNOWLEDGMENT -- REFERENCES -- 4 - Subclinical Cardiovascular Damage in Systemic Rheumatic Diseases -- 1. INTRODUCTION -- 2. EPIDEMIOLOGY AND ROLE OF TRADITIONAL RISK FACTORS -- 2.1 Rheumatoid Arthritis -- 2.2 Systemic Lupus Erythematosus -- 2.3 Psoriatic Arthritis -- 2.4 Ankylosing Spondylitis -- 2.5 Systemic Sclerosis -- 3. SUBCLINICAL ATHEROSCLEROSIS -- 3.1 Rheumatoid Arthritis -- 3.2 Systemic Lupus Erythematosus -- 3.3 Psoriatic Arthritis -- 3.4 Ankylosing Spondylitis -- 3.5 Systemic Sclerosis -- 4. CARDIOVASCULAR EFFECTS OF PHARMACOLOGICAL TREATMENTS -- 4.1 Rheumatoid Arthritis -- 4.1.1 Nonsteroidal Antiinflammatory Drugs -- 4.1.2 Glucocorticoids -- 4.1.3 Nonbiologic Disease-Modifying Antirheumatic Drugs -- 4.1.4 Biologic Disease-Modifying Antirheumatic Drugs. 4.1.5 Statins -- 4.2 Systemic Lupus Erythematosus -- 4.2.1 Glucocorticoids -- 4.2.2 Hydroxychloroquine -- 4.2.3 Immunosuppressive Treatment -- 4.2.4 Statins -- 4.3 Psoriatic Arthritis -- 4.3.1 Biologic Disease-Modifying Antirheumatic Drugs -- 4.4 Ankylosing Spondylitis -- 4.4.1 Biologic Disease-Modifying Antirheumatic Drugs -- 4.4.2 Statins -- 4.5 Systemic Sclerosis -- REFERENCES -- 5 - Atherosclerosis and Autoimmunity -- 1. INTRODUCTION -- 2. PREVALENCE AND EPIDEMIOLOGY -- 3. PATHOGENESIS -- 3.1 Genetic Background -- 3.2 Subclinical Atherosclerosis: Endothelial Dysfunction and Atherosclerotic Plaque Formation -- 3.3 Autoantigens and Autoantibodies in Atherosclerosis -- 3.4 Cellular Mechanisms -- 3.5 The Role of β2GPI -- 3.6 Anticardiolipin Antibodies -- 3.7 Anti-oxLDL Antibodies -- 3.8 Anti-apoA-1 Antibodies -- 3.9 Inflammatory Chemokines and Cytokines in Autoimmune Atherosclerosis -- 3.10 Heat-Shock Proteins as Autoantigens in Atherosclerosis -- 3.11 Other Factors: Vitamin D and Obesity -- 3.12 Systemic Lupus Erythematosus and Atherosclerosis -- 3.13 Rheumatoid Arthritis and Atherosclerosis -- 4. CLINICAL MANIFESTATIONS -- 5. DIAGNOSTIC INVESTIGATIONS -- 6. TREATMENT -- REFERENCES -- 6 - Inflammasomes and Inflammatory Cytokines in Early Atherosclerosis -- 1. INTRODUCTION -- 2. LIPID DYSREGULATION IN AUTOIMMUNITY -- 3. INNATE IMMUNITY AND INFLAMMATORY SIGNALING MECHANISMS -- 4. INFLAMMASOMES AND IL-1β IN ATHEROGENESIS -- 5. β2-GLYCOPROTEIN I IN ATHEROGENIC INNATE IMMUNITY -- 6. SUMMARY AND CONCLUSIONS -- ACKNOWLEDGMENTS -- REFERENCES -- 7 - Treatment of Lipid Metabolism Disturbances in Autoimmune Diseases -- 1. INTRODUCTION -- 2. LIPID METABOLISM DISTURBANCES RELEVANT FOR ATHEROSCLEROSIS AND CARDIOVASCULAR RISK IN AUTOIMMUNE DISEASES -- 3. SERUM LIPID LEVEL CONTROL IN AUTOIMMUNE DISEASES -- 3.1 Diet and Nutraceuticals. 3.2 Total Cholesterol- and Low-Density Lipoprotein Cholesterol-Lowering Drugs: Statins -- 3.2.1 Potential and Proven Benefits of Statin Use in Patients With Autoimmune Diseases -- 3.2.1.1 Effects on the Autoimmune Disease -- 3.2.1.2 Effects on Lipid Metabolism and Cardiovascular Disease -- 3.2.2 Potential Harms of Statin Use in Patients With Autoimmune Diseases -- 3.3 Total Cholesterol- and Low-Density Lipoprotein Cholesterol-Lowering Drugs: Fibrates -- 3.4 High-Density Lipoprotein Cholesterol Increasing Drugs -- 4. LIPOPROTEIN FUNCTION MODULATION IN AUTOIMMUNE DISEASES -- REFERENCES -- 8 - Cardiac Imaging Techniques in Systemic Autoimmune Diseases -- 1. INTRODUCTION -- 2. TRANSTHORACIC ECHOCARDIOGRAPHY -- 3. TRANSESOPHAGEAL ECHOCARDIOGRAPHY -- 4. STRESS ECHOCARDIOGRAPHY -- 5. TISSUE DOPPLER IMAGING -- 6. SPECKLE TRACKING ECHOCARDIOGRAPHY -- 7. MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY -- 8. USEFULNESS OF BIOMARKERS OF ENDOTHELIAL DYSFUNCTION -- 9. CAROTID ULTRASONOGRAPHY -- 9.1 Carotid Atherosclerosis -- 10. CONCLUSION -- REFERENCES -- FURTHER READING -- 9 - New Cardiac Imaging Tools and Invasive Techniques in Systemic Autoimmune Diseases (Part II) -- 1. INTRODUCTION -- 2. CARDIAC MAGNETIC RESONANCE IMAGING -- 2.1 Cardiac Magnetic Resonance Imaging Techniques -- 2.1.1 Cine Imaging -- 2.1.2 T2-Weighted Imaging -- 2.1.3 First-Pass Myocardial Perfusion Imaging -- 2.1.4 Late Gadolinium Enhancement Imaging -- 2.2 Clinical Role and Indications for Cardiac Magnetic Resonance Imaging -- 2.2.1 Ischemic Cardiomyopathy -- 2.2.2 Interstitial Fibrosis -- 2.2.3 Infiltrative Cardiomyopathies -- 2.2.4 Valve Dysfunction -- 2.2.5 Arrhythmogenic Right Ventricular Dysplasia -- 2.2.6 Constrictive Pericarditis -- 2.2.7 Inflammatory Vasculitis -- 3. COMPUTED TOMOGRAPHY -- 3.1 Coronary Calcium Scoring -- 3.2 Coronary Computed Tomography Angiography -- 3.3 Pericardial Disease. 4. RIGHT HEART CATHETERIZATION -- 5. ENDOMYOCARDIAL BIOPSY -- 5.1 Biopsy Technique -- 5.2 Complications -- 6. CONCLUSION -- ACKNOWLEDGMENT -- REFERENCES -- 10 - Cardiac Diseases in Rheumatoid Arthritis -- 1. INTRODUCTION -- 1.1 Rheumatoid Arthritis -- 1.2 Mortality in Rheumatoid Arthritis -- 2. ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS -- 2.1 Introduction -- 2.2 Epidemiology -- 2.3 Etiology of Ischaemic Heart Disease in Rheumatoid Arthritis -- 2.3.1 Traditional Cardiovascular Risk Factors -- 2.3.1.1 Hypertension -- 2.3.1.2 Smoking -- 2.3.1.3 Lipids -- 2.3.1.4 Insulin Resistance and Diabetes Mellitus -- 2.3.1.5 Physical Activity -- 2.3.1.6 Body Weight and Composition -- 2.3.2 Other Cardiovascular Risk Factors -- 2.4 Inflammation and Cardiovascular Disease in Rheumatoid Arthritis -- 2.5 Cardiovascular Risk Assessment in Rheumatoid Arthritis -- 2.5.1 Added Value of Novel Biomarkers and Imaging -- 2.6 Treatment -- 2.6.1 Antiinflammatory Therapy and Cardiovascular Risk -- 2.6.2 Treatment of Cardiovascular Risk Factors and Cardiovascular Disease in Rheumatoid Arthritis -- 3. NONATHEROSCLEROTIC CARDIOVASCULAR DISEASE -- 3.1 Pericardial Disease -- 3.1.1 Introduction -- 3.1.2 Prevalence -- 3.1.3 Etiology of Pericardial Involvement in Rheumatoid Arthritis -- 3.1.4 Mortality -- 3.1.5 Pathology -- 3.1.6 Clinical Manifestations -- 3.1.7 Diagnostic Investigations -- 3.1.8 Differential Diagnosis and Management -- 3.2 Endocardial Involvement in Rheumatoid Arthritis -- 3.2.1 Valvular Disease -- 3.2.2 Coronary Arteritis -- 3.3 Myocardial Involvement and Conduction System Abnormalities in Rheumatoid Arthritis -- 4. CONCLUSION -- REFERENCES -- 11 - Cardiac Involvement in Systemic Lupus Erythematosus -- 1. INTRODUCTION -- 2. PERICARDIAL INVOLVEMENT -- 2.1 Prevalence -- 2.2 Histopathologic Findings/Pathogenesis -- 2.3 Clinical Features. 2.4 Diagnostic Investigations. |
| Record Nr. | UNINA-9910583313103321 |
Atzeni Fabiola
|
||
| Amsterdam ; ; Cambridge, Massachusetts : , : Elsevier, , [2017] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Inflammatory diseases of blood vessels / / edited by Gary S. Hoffman ... [et al.]
| Inflammatory diseases of blood vessels / / edited by Gary S. Hoffman ... [et al.] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Chichester [England], : Wiley-Blackwell, 2012 |
| Descrizione fisica | 1 online resource (598 p.) |
| Disciplina | 616.1/3 |
| Altri autori (Persone) | HoffmanGary S. <1942-> |
| Soggetto topico |
Vasculitis
Inflammation Blood-vessels - Diseases |
| ISBN |
9786613615343
9781118355275 111835527X 9781280585517 128058551X 9781118355251 1118355253 9781118355244 1118355245 9781118355268 1118355261 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Machine generated contents note: List of Contributors Preface Section I. Biology of Blood Vessels and Mechanisms of Vascular Inflammation 1. Vascular Development Domenico Ribatti and Enrico Crivellato 2. Vascular Repair Christian Troidl, Kerstin Troidl, Georg Jung, Thomas Schmitz-Rixen and Wolfgang Schaper 3. Leukocyte Trafficking Braedon McDonald and Paul Kubes 4. Dendritic Cells and Vascular Inflammation Cornelia M. Weyand 5. T Cells and Vascular Inflammation Jörg J. Goronzy 6. Autoantibodies and Vascular Inflammation A. Rutgers, J.S.F. Sanders, J.W. Cohen Tervaert, C.G.M. Kallenberg 7. Neutrophils and Vascular Inflammation Matthew David Morgan and Caroline OS Savage 8. Cytokines and Vascular Inflammation Maria C Cid, Marc Corbera-Bellalta, Ester Planas-Rigol, Ester Lozano, Georgina Espigol-Frigole, Ana Garcia-Martinez, Jose Hernández-Rodriguez, Marta Segarra 9. Oxidative Stress and Vascular Inflammation David G. Harrison 10. Hemostasis and Vascular Inflammation Lawrence Leung and John Morser 11. Animal Models of Vasculitis Masato Nose 12. Arteries, Smooth Muscle Cells, and Genetic Causes of Thoracic Aortic Aneurysms Amy J. Reid and Dianna M. Milewicz 13. Innate Immunity in Atherosclerosis Shuang Chen, Prediman K. Shah and Moshe Arditi 14. Adaptive Immunity in Atherosclerosis Jan Nilsson Section II. Primary Autoimmune Vascular Diseases 15. Historical Perspectives Vasculitis Eric L. Matteson 16. Approach to the Differential Diagnosis of Vasculitis Eamonn S. Molloy and Carol A. Langford 17. Imaging of medium and large vessels (CT/PET/MR) Thorsten Alexander Bley 18. Kawasaki disease Rae S.M. Yeung 19. Henoch-Schonlein Purpura Philip J. Hashkes and Alexandra Villa-Forte 20. Polyarteritis Nodosa Eli M. Miloslavsky and John H. Stone 21. Microscopic polyangiitis Coen Stegeman 22 Granulomatosis with Polyangiitis (Wegener's Granulomatosis) Gary S. Hoffman, Carol A. Langford and Ulrich Specks 23. Churg-Strauss Syndrome (Eosinophilic Granulomatosis with Polyangiitis, EGPA) Christian Pagnoux and Loic Guillevin 24. Giant cell arteritisCornelia M. Weyand and Jörg J. Goronzy 25. Takayasu's arteritis Kathleen Maksimowicz-McKinnon and Gary S. Hoffman 26. Behçet's Syndrome Yusuf Yazici, Ismail Simsek and Hasan Yazici 27. Cogan's Syndrome Rex M. McCallum and E. William St. Clair 28. Idiopathic cryoglobulinemic vasculitides Benjamin Terrier and Patrice Cacoub 29. Primary central nervous system vasculitis Rula A. Hajj-Ali and Leonard H. Calabrese 30. Single organ vasculitis Jose Hernández-Rodriguez and Gary S. Hoffman 31. Primary cutaneous vasculitis Jeffrey P. Callen 32. Buerger's disease (thromboangiitis obliterans) Ahmet Ruchan Akar and M. Serkan Durdu Section III. Secondary Causes of Vasculitis 33. Virus-associated vasculitides Dimitrios Vassilopoulos and Leonard H. Calabrese 34. Drug-induced vasculitis Peter A. Merkel 35. Rheumatoid vasculitis Kimberly P. Liang, Carl Turesson, Larry W. Moreland 36. Vasculopathy/Vasculitis and progressive systemic sclerosis Nezam Altorok, Omar R. Kahaly and Bashar Kahaleh 37. Vasculitis and Sjögren's syndrome George E. Fragoulis and Haralampos M. Moutsopoulos 38. Vasculitis in systemic lupus erythematosus Ricardo Garcia and Andras Perl 39. Vasculitis in the Idiopathic Inflammatory Myopathies Frederick W. Miller and Chester V. Oddis 40. Vasculitis and relapsing polychondritis Tanaz A. Kermani and Kenneth J. Warrington 41. Systemic Vasculitis in Sarcoidosis Alexandra Villa-Forte and Gary S. Hoffman 42. Vasculitis as a Paraneoplastic Syndrome and Direct Tumour Invasion of Vessels Claire E. Barber and Simon Carette Section IV. Recognizing Risks and Treating Damage from Vasculitis 43. Cholesterol and Modifications of Cholesterol in Rheumatic Disorders Jan Willem Cohen Tervaert 44. Prevention and treatment of medical complications Atul Khasnis and Carol A. Langford 45. Ophthalmic Risks and Complications Associated with the Treatment of Systemic Vasculitis Steven Yeh and James T. Rosenbaum 46. Subglottic Stenosis of Granulomatosis with Polyangiitis (Wegener's Granulomatosis) Rahul Seth and Daniel S. Alam 47. Sino-Nasal Manifestations of Granulomatosis with Polyangiitis (Wegener's Granulomatosis) Daniel S. Alam, Rahul Seth, Raj Sindwani 48. Neurologic Damage of Vasculitis C. David Lin 49. Endstage Renal Disease and Vasculitis Kirsten de Groot and Charles Pusey 50. Cardiothoracic Surgery for Takayasu's Arteritis and Giant Cell ArteritisTurki Albacker and Lars Svensson 51. Peripheral Vascular Surgery for Takayasu's Arteritis and Giant Cell Arteritis Ravi R. Rajani and Vikram S. KashyapIndex. |
| Record Nr. | UNINA-9910141270303321 |
| Chichester [England], : Wiley-Blackwell, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Large and medium size vessel and single organ vasculitis / / edited by Carlo Salvarani, Luigi Boiardi, Francesco Muratore
| Large and medium size vessel and single organ vasculitis / / edited by Carlo Salvarani, Luigi Boiardi, Francesco Muratore |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (274 pages) |
| Disciplina | 616.13 |
| Collana | Rare Diseases of the Immune System |
| Soggetto topico | Vasculitis |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-67175-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Contents -- Part I: Giant Cell Arteritis -- 1: Classification Criteria -- References -- 2: Epidemiology and Genetics -- 2.1 Epidemiology -- 2.2 Genetics -- References -- 3: Pathogenesis -- 3.1 Introduction -- 3.2 Model of GCA Pathogenesis -- 3.3 Role of Infectious Agents -- 3.4 Genetics -- 3.5 Immune Effectors of Inflammation in Arteries -- 3.6 Arterial Remodeling -- 3.7 Epigenetics -- 3.8 MicroRNA -- 3.9 Deregulation of the Immune System in Peripheral Blood -- 3.10 Pathways Proven to be Involved in GCA Pathogenesis -- References -- 4: Clinical Manifestations, Differential Diagnosis, and Laboratory Markers -- 4.1 Clinical Manifestations of Giant Cell Arteritis -- 4.2 Differential Diagnosis of Giant Cell Arteritis -- 4.3 Laboratory Markers -- References -- 5: Histopathology and Imaging -- 5.1 Imaging -- 5.2 Temporal Artery Imaging -- 5.3 Large-Vessel Imaging -- References -- 6: Prognosis and Disease Activity -- 6.1 Risk for Complications and Comorbidities During Disease Course -- 6.2 Risk Factors and Biomarkers for Disease Activity in Giant Cell Arteritis -- 6.3 Additional Biomarkers for Assessment of Prognosis-Relevant Comorbidities -- References -- 7: Treatment and Management -- 7.1 General Aspects -- 7.2 Glucocorticoids as First-Line Treatment -- 7.3 Glucocorticoid(GC)-Sparing Agents -- 7.4 Treatment of Comorbidities/Adjuvant Therapies -- References -- Part II: Takayasu Arteritis -- 8: Classification Criteria, Epidemiology and Genetics -- and Pathogenesis -- 8.1 Classification Criteria -- 8.2 Epidemiology and Genetics -- 8.2.1 Incidence and Prevalence -- 8.2.2 Sex -- 8.2.3 Age at Diagnosis -- 8.2.4 Major Histocompatibility Complex -- 8.2.5 Non-MHC -- 8.3 Pathogenesis -- References -- 9: Clinical Manifestations, Differential Diagnosis, and Laboratory Markers -- 9.1 Clinical Manifestations.
9.2 Physical Examination -- 9.3 Laboratory: Role of Acute-Phase Response -- 9.4 Differential Diagnosis -- 9.5 Large-Vessel Vasculitis Mimickers in the Differential Diagnosis of TAK -- References -- 10: Imaging -- 10.1 CTA -- 10.2 MRA -- 10.3 FDG-PET -- 10.4 Ultrasonography -- 10.5 Conclusion -- References -- 11: Prognosis and Disease Activity -- 11.1 Disease Activity Assessment -- 11.1.1 Physical Examination in Clinical Activity Assessment -- 11.1.2 Laboratory in Disease Activity Assessment -- 11.1.3 Imaging in Disease Activity Assessment -- 11.1.4 Outcome Measures in Disease Activity Assessment -- 11.2 Prognosis -- 11.2.1 Disease Course -- 11.2.2 Damage Assessment in TAK -- 11.2.3 Mortality -- 11.3 Conclusion -- References -- 12: Treatment -- 12.1 Non-biologic Disease-Modifying Agents -- 12.1.1 Methotrexate -- 12.1.2 Azathioprine -- 12.1.3 Leflunomide -- 12.1.4 Mycophenolate Mofetil -- 12.1.5 Cyclophosphamide -- 12.1.6 Other Non-biologic Disease-Modifying Agents -- 12.2 Biologic Disease-Modifying Agents -- 12.2.1 Tumor Necrosis Factor Inhibitors -- 12.2.2 Tociluzumab -- 12.2.3 Rituximab -- 12.2.4 Other Biologic Disease-Modifying Agents -- 12.3 Vascular Interventions and Surgical Therapy -- 12.4 Conclusion -- References -- Part III: Polyarteritis Nodosa -- 13: Cutaneous Polyarteritis Nodosa -- 13.1 Introduction -- 13.2 Epidemiology, Genetics, Pathogenesis -- 13.3 Clinical Manifestations and Laboratory Markers -- 13.3.1 Clinical Manifestations -- 13.3.2 Laboratory Markers -- 13.4 Histopathology -- 13.5 Diagnosis and Differential Diagnosis -- 13.6 Treatment -- 13.7 Prognosis and Disease Activity -- References -- 14: Systemic Polyarteritis Nodosa -- 14.1 Introduction -- 14.2 Epidemiology -- 14.3 Etiopathogenesis -- 14.4 Clinical Manifestations and Laboratory Markers -- 14.4.1 Clinical Manifestations. 14.4.2 Laboratory Markers -- 14.5 Histopathology -- 14.6 Diagnosis and Differential Diagnosis -- 14.7 Prognosis -- 14.8 Treatment -- References -- Part IV: Single Organ Vasculitis -- 15: Adult Primary Central Nervous System Vasculitis -- 15.1 Introduction -- 15.2 Diagnosis and Diagnostic Criteria -- 15.3 Histopathology -- 15.4 Clinical Manifestations and Laboratory Findings -- 15.5 PCNSV Subsets -- 15.6 Differential Diagnosis -- 15.7 Treatment -- 15.7.1 Mayo Clinic Cohort of Patients with Adult PCNSV -- 15.7.2 French Cohort of Patients with Primary Central Nervous System Vasculitis -- 15.7.3 Monitoring Disease Course -- References -- 16: Isolated Aortitis and Periaortitis -- 16.1 Introduction -- 16.2 Clinical Features and Diagnosis -- 16.2.1 Isolated Aortitis -- 16.2.2 Periaortitis -- 16.2.3 IgG4-Related Aortitis and Periaortitis -- 16.3 Treatment -- 16.4 Conclusions -- References -- 17: Isolated Gastrointestinal Vasculitis -- 17.1 Introduction -- 17.2 Epidemiology -- 17.3 Clinical Manifestations -- 17.4 Diagnosis -- 17.5 Differential Diagnosis -- 17.6 Management -- 17.7 Prognosis -- References -- 18: Cutaneous Vasculitis -- 18.1 Introduction -- 18.2 Nomenclature and Classification of Cutaneous Vasculitis -- 18.3 Clinical Spectrum of Cutaneous Vasculitis -- 18.4 Cutaneous Vasculitic Manifestations in Systemic Vasculitides with Predominant Organ Involvement Different from the Skin -- 18.4.1 Polyarteritis Nodosa -- 18.4.2 Anti-neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis -- 18.4.2.1 MPA -- 18.4.2.2 GPA -- 18.4.2.3 EGPA -- 18.4.3 Immune Complex Small-Vessel Vasculitis -- 18.4.3.1 IgA Vasculitis (IgAV) -- 18.4.3.2 Cryoglobulinemic Vasculitis -- 18.4.3.3 Urticarial Vasculitis -- 18.5 Cutaneous Vasculitis Associated with Autoimmune Systemic Diseases -- 18.5.1 Rheumatoid Arthritis (RA). 18.5.2 Systemic Lupus Erythematous (SLE) -- 18.5.3 Primary Sjögren Syndrome (PSS) -- 18.6 Cutaneous Single-Organ Vasculitis (SOV) -- 18.6.1 Erythema Elevatum et Diutinum (EED) -- 18.6.2 Nodular Vasculitis (Erythema Induratum of Bazin) -- 18.6.3 Hypergammaglobulinemic Macular Vasculitis (Hypergammaglobulinemic Purpura of Waldenström) -- 18.7 Diagnostic Approach in a Patient Presenting with Cutaneous Vasculitis -- 18.8 Treatment of Cutaneous Vasculitis -- References -- 19: Single-Organ Genitourinary Vasculitis -- 19.1 Introduction -- 19.2 Gynecologic Single-Organ Vasculitis -- 19.3 Male Genital Tract Single-Organ Vasculitis -- 19.3.1 Testicles, Epididymis, and Spermatic Cords -- 19.3.2 Prostate, Seminal Vesicles, and Penis -- 19.4 Urinary Tract Single-Organ Vasculitis -- 19.4.1 Ureters -- 19.4.2 Urinary Bladder -- 19.4.3 Urethra -- 19.5 Conclusions -- References -- Part V: Arterial and Venous Involvement in Behçet's Disease -- 20: Arterial and Venous Involvement in Behçet's Disease -- 20.1 Epidemiology -- 20.2 Pathology -- 20.3 Pathophysiology -- 20.4 Clinical Features and Prognosis of Venous Involvement -- 20.4.1 Deep Vein Thrombosis of Lower Extremities -- 20.4.2 Venous Wall Thickness in Behçet's Disease -- 20.4.3 Thrombosis of Superior and Inferior Vena Cava -- 20.4.4 Budd-Chiari Syndrome -- 20.4.5 Cerebral Sinus Thrombosis -- 20.5 Clinical Features and Prognosis of Arterial Involvement -- 20.5.1 Pulmonary Arterial Involvement -- 20.5.2 Peripheral Arterial Involvement -- 20.5.3 Cardiac Involvement -- 20.6 Imaging in Vascular Involvement of Behçet's Disease -- 20.7 Diagnosis -- 20.8 Treatment -- 20.8.1 Medical Treatment -- 20.9 Anticoagulation -- 20.10 Surgical Treatment -- 20.11 Conclusion -- References -- Correction to: Isolated Gastrointestinal Vasculitis. Correction to: C. Salvarani et al. (eds.), Large and Medium Size Vessel and Single Organ Vasculitis, Rare Diseases of the Immune System, https://doi.org/10.1007/978-3-030-67175-4_17 -- Index. |
| Record Nr. | UNINA-9910484921203321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / / World Association of Sarcoidosis and Other Granulomatous Disorders
| Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / / World Association of Sarcoidosis and Other Granulomatous Disorders |
| Pubbl/distr/stampa | Cormano, Milan, Italy, : PCA Pub., ©1996- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Sarcoidosis
Lungs - Diseases Ziekte van Besnier-Boeck Granuloma Lung Diseases, Interstitial Vasculitis |
| Soggetto genere / forma |
Periodicals.
Periodical |
| ISSN | 2532-179X |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996203945403316 |
| Cormano, Milan, Italy, : PCA Pub., ©1996- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / / World Association of Sarcoidosis and Other Granulomatous Disorders
| Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / / World Association of Sarcoidosis and Other Granulomatous Disorders |
| Pubbl/distr/stampa | Cormano, Milan, Italy, : PCA Pub., ©1996- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Sarcoidosis
Lungs - Diseases Ziekte van Besnier-Boeck Granuloma Lung Diseases, Interstitial Vasculitis |
| Soggetto genere / forma |
Periodicals.
Periodical |
| ISSN | 2532-179X |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910144708203321 |
| Cormano, Milan, Italy, : PCA Pub., ©1996- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Vasculitis in practice : an update on special situations - clinical and therapeutic considerations / / edited by Reem Hamdy Abdellatif Mohammed
| Vasculitis in practice : an update on special situations - clinical and therapeutic considerations / / edited by Reem Hamdy Abdellatif Mohammed |
| Pubbl/distr/stampa | London, England : , : IntechOpen, , [2018] |
| Descrizione fisica | 1 online resource (112 pages) : illustrations |
| Disciplina | 616.13 |
| Soggetto topico | Vasculitis |
| ISBN |
1-83881-423-X
1-78923-699-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Vasculitis in practice |
| Record Nr. | UNINA-9910317790503321 |
| London, England : , : IntechOpen, , [2018] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Vasculitis
(8)
- Granuloma (2)
- Immunology (2)
- Lung Diseases, Interstitial (2)
- Lungs - Diseases (2)